DE69224293T2 - Vanadium enthaltende zusammensetzungen - Google Patents

Vanadium enthaltende zusammensetzungen

Info

Publication number: DE69224293T2
Authority: DE; Germany
Prior art keywords: compositions; vanadium; vanadium compositions; oxovanadium; monoprotic
Prior art date: 1991-09-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69224293T

Other languages

English (en)

Other versions

DE69224293D1 (de

Inventor

John Hugh Mcneill

Hamid Reza Hoveyda

Chris Orvig

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of British Columbia

Original Assignee

University of British Columbia

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-09-30

Filing date

1992-09-29

Publication date

1998-07-09

1992-09-29 Application filed by University of British Columbia filed Critical University of British Columbia

1998-03-05 Publication of DE69224293D1 publication Critical patent/DE69224293D1/de

1998-07-09 Application granted granted Critical

1998-07-09 Publication of DE69224293T2 publication Critical patent/DE69224293T2/de

2012-09-30 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

DE69224293T 1991-09-30 1992-09-29 Vanadium enthaltende zusammensetzungen Expired - Fee Related DE69224293T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/767,510 US5300496A (en)	1991-09-30	1991-09-30	Complexed vanadium for the treatment of diabetes mellitus
PCT/EP1992/002235 WO1993006811A2 (en)	1991-09-30	1992-09-29	Vanadium compositions

Publications (2)

Publication Number	Publication Date
DE69224293D1 DE69224293D1 (de)	1998-03-05
DE69224293T2 true DE69224293T2 (de)	1998-07-09

Family

ID=25079727

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69224293T Expired - Fee Related DE69224293T2 (de)	1991-09-30	1992-09-29	Vanadium enthaltende zusammensetzungen

Country Status (13)

Country	Link
US (1)	US5300496A (de)
EP (2)	EP0606318B1 (de)
JP (1)	JP3515107B2 (de)
AT (1)	ATE162716T1 (de)
AU (1)	AU2649792A (de)
CA (1)	CA2120338A1 (de)
DE (1)	DE69224293T2 (de)
DK (1)	DK0606318T3 (de)
ES (1)	ES2112329T3 (de)
GR (1)	GR3026654T3 (de)
NZ (1)	NZ244569A (de)
WO (1)	WO1993006811A2 (de)
ZA (1)	ZA927522B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5866563A (en) *	1991-09-30	1999-02-02	The University Of British Columbia	Vanadium compositions
US5527790A (en) *	1991-09-30	1996-06-18	The University Of British Columbia	Bis(maltolato)oxovanadium compositions for the treatment of elevated blood sugar
GB9305735D0 (en) *	1993-03-19	1993-05-05	North John R	Novel agent for controlling cell activity
US5871779A (en) *	1994-01-18	1999-02-16	Mount Sinai Hospital Corporation	Treatment of arthropathies with vanadate compounds or analogues thereof
US5565491A (en) *	1994-01-31	1996-10-15	Bristol-Myers Squibb Company	Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
GB9416768D0 (en) *	1994-08-18	1994-10-12	Nycomed Innovation Ab	Compositions
US5863519A (en) *	1994-08-18	1999-01-26	Nycomed Imaging As	Composition and method of MRI using both a positive and a negative contrast agent
GB9416767D0 (en) *	1994-08-18	1994-10-12	Nycomed Innovation Ab	Compositions
WO1996005867A2 (en) *	1994-08-18	1996-02-29	Nycomed Imaging A/S	Compositions
US5545661A (en) *	1995-05-16	1996-08-13	Eli Lilly And Company	Methods for inhibiting bone loss with bis-pyrone oxovanadium compounds
US5547685A (en) *	1995-05-16	1996-08-20	Eli Lilly And Company	Methods for inhibiting bone loss with vanadyl sulfate
US5885980A (en) *	1996-06-25	1999-03-23	Enrique G. Gutierrez	Composition and method for treating diabetes
US5962030A (en)	1997-03-07	1999-10-05	Akesis Pharmaceuticals, Inc.	Dietary supplement and method of treatment for diabetic control
EP0984971A1 (de) *	1997-04-24	2000-03-15	Angiotech Pharmaceuticals, Inc.	Vanadiumkomplexe und deren derivate und damit verwandte herstellungsverfahren
US6232340B1 (en)	1997-04-24	2001-05-15	Angiotech Pharmaceuticals, Inc.	Vanadium complexes and derivatives thereof and methods related thereto
US6432941B1 (en) *	1998-01-20	2002-08-13	Parker Hughes Institute	Vanadium compounds for treating cancer
US6245808B1 (en) *	1998-11-05	2001-06-12	Parker Hughes Institute	Oxy-vanadium (IV) complexes having spermicidal activity
CA2344246A1 (en)	1998-09-17	2000-03-23	Akesis Pharmaceuticals, Inc.	Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
US6376549B1 (en) *	1998-09-17	2002-04-23	Akesis Pharmaceuticals, Inc.	Metforimin-containing compositions for the treatment of diabetes
US6287586B1 (en)	1998-09-18	2001-09-11	The University Of British Columbia	Pharmaceutical compositions of vanadium biguanide complexes and their use
WO2000024730A1 (en) *	1998-10-28	2000-05-04	The University Of British Columbia	Organic vanadium(iii) complexes and their use
GB2396106B (en) *	2002-12-12	2006-11-15	Johnson & Johnson Medical Ltd	Wound dressings comprising enzyme inhibitors
CN101068769A (zh) *	2004-07-02	2007-11-07	根梅迪卡治疗公司	治疗和/或预防糖尿病的芳烷基胺钒（v）盐
MX2007007183A (es) *	2004-12-16	2008-01-14	Genmedica Therapeutics Sl	Aminas, combinacion de aminas y vanadio y sales de amina y vanadio para el tratamiento o prevencion de dislipidemia.
US20070066682A1 (en) *	2005-07-01	2007-03-22	Exposito Miriam R	Arylalkylamine vanadium (V) salts for the treatment and/or prevention of Diabetes mellitus
WO2007131996A1 (en) *	2006-05-12	2007-11-22	Genmedica Therapeutics Sl	Meta-xylylenediamine vanadate salts
EP2683374B8 (de)	2011-03-07	2019-11-13	CFM Pharma Holding BV	Verwendung von vanadiumverbindungen zur bewahrung der normoglykämie bei einem säuger
WO2012131689A1 (en)	2011-03-25	2012-10-04	Chaudhuri Mihir K	Insulin mimetic active comprising oxodiperoxo vanadates and a pharamaceutical composition obtained thereof
EP3988092A4 (de) *	2019-06-24	2022-08-24	Hunan Fangshengtai Medical Technology Co., Ltd.	Neue anwendung von metallkomplex
CN111035652B (zh) *	2020-01-08	2021-08-24	辽宁大学	钒酸盐酪蛋白复合物在制备降糖药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1277599C (en) *	1986-10-16	1990-12-11	Barry I. Posner	Vanadium - peroxide compositions as insulin mimickers
FR2619382B1 (fr) *	1987-08-11	1990-05-04	Lazaro Rene	Compose organo-mineral de vanadyle, procede d'obtention d'un tel compose, composition pharmaceutique contenant ce compose organo-mineral
JPH02292217A (ja) *	1989-05-08	1990-12-03	Otsuka Pharmaceut Co Ltd	糖尿病治療薬

1991
- 1991-09-30 US US07/767,510 patent/US5300496A/en not_active Expired - Lifetime
1992
- 1992-09-29 AT AT92920526T patent/ATE162716T1/de not_active IP Right Cessation
- 1992-09-29 EP EP92920526A patent/EP0606318B1/de not_active Expired - Lifetime
- 1992-09-29 AU AU26497/92A patent/AU2649792A/en not_active Abandoned
- 1992-09-29 WO PCT/EP1992/002235 patent/WO1993006811A2/en active IP Right Grant
- 1992-09-29 EP EP97200558A patent/EP0811380A3/de not_active Withdrawn
- 1992-09-29 ES ES92920526T patent/ES2112329T3/es not_active Expired - Lifetime
- 1992-09-29 CA CA002120338A patent/CA2120338A1/en not_active Abandoned
- 1992-09-29 DE DE69224293T patent/DE69224293T2/de not_active Expired - Fee Related
- 1992-09-29 DK DK92920526T patent/DK0606318T3/da active
- 1992-09-29 JP JP50659193A patent/JP3515107B2/ja not_active Expired - Fee Related
- 1992-09-30 NZ NZ244569A patent/NZ244569A/en unknown
- 1992-09-30 ZA ZA927522A patent/ZA927522B/xx unknown
1998
- 1998-04-15 GR GR980400857T patent/GR3026654T3/el unknown

Also Published As

Publication number	Publication date
NZ244569A (en)	1995-04-27
EP0811380A3 (de)	1999-01-20
JP3515107B2 (ja)	2004-04-05
EP0606318A1 (de)	1994-07-20
CA2120338A1 (en)	1993-04-15
ZA927522B (en)	1993-06-16
WO1993006811A2 (en)	1993-04-15
WO1993006811A3 (en)	1993-06-24
GR3026654T3 (en)	1998-07-31
DE69224293D1 (de)	1998-03-05
JPH06511244A (ja)	1994-12-15
ES2112329T3 (es)	1998-04-01
ATE162716T1 (de)	1998-02-15
AU2649792A (en)	1993-05-03
EP0606318B1 (de)	1998-01-28
DK0606318T3 (da)	1998-09-23
US5300496A (en)	1994-04-05
EP0811380A2 (de)	1997-12-10

Legal Events

Date	Code	Title	Description
1999-03-04	8364	No opposition during term of opposition
2004-07-08	8339	Ceased/non-payment of the annual fee

Publication	Publication Date	Title
DE69224293D1 (de)	1998-03-05	Vanadium enthaltende zusammensetzungen
ATE157024T1 (de)	1997-09-15	Verfahren zur deliquifizierung und zum bleichen von einem ligenocellulosischen material
MXPA02003122A (es)	2004-04-21	Acidos indolalcanoicos substituidos.
ATE523194T1 (de)	2011-09-15	Bis(thiohydrazidamide) in kombination mit taxol für die behandlung von krebs
MY129973A (en)	2007-05-31	Sulphonylbenzyl-substituted pyridones.
NO941770L (no)	1994-11-14	Substituert mono- og bipyridylmetylpyridon
ATE259644T1 (de)	2004-03-15	Behandlung von hämoglobin enthaltenden erythrozyten mit stickstoffoxyd
IS4967A (is)	1999-02-05	Bindill tengdur æxlisdrepthætti
AU3245489A (en)	1989-11-02	Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer
DE69703228T2 (de)	2001-02-22	Neue 6-Hydroxy und 6-Oxo-Androstan Verbindungen mit Kardioaktivität und pharmazeutische Präparate davon
DE69122282T2 (de)	1997-04-24	Komplexe und Chelate des Azithromycins als Antiulcus-Mittel
GEP20032914B (en)	2003-03-25	Derivatives of 1,3,4-Oxadiazolone
DE3575554D1 (de)	1990-03-01	Aminosaeurederivate mit antitumoraktivitaet sowie diese derivate enthaltende zusammensetzungen.
DK0977582T3 (da)	2002-12-16	Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater
EP0202673A3 (en)	1987-03-25	Titanocene complexes having a cytostatic activity
DK0684259T3 (da)	2000-05-08	L-Lysyl-glycyl-L-histidin og terapeutiske præparater med indhold deraf til sårheling
DE69519049D1 (de)	2000-11-16	Polymerisationskatalysatoren
EP0037144A3 (de)	1981-11-25	Chromkomplexe als Diätzulage und pharmazeutische Mittel
DK0688786T3 (da)	1997-09-15	Hydrazino- og hydroxyamino-14beta-hydroxyandrostanderivater med aktivitet på det cardiovaskulære system, fremgangsmåder til deres fremstilling og farmaceutiske præparater indeholdende disse.
EP0316709A3 (en)	1990-04-25	Proteinaceous derivatives containing iron in highly bioaproteinaceous derivatives containing iron in highly bioavailable form, preparation thereof and pharmaceutical covailable form, preparation thereof and pharmaceutical compositions containing them mpositions containing them
DE58905990D1 (de)	1993-12-02	Antihypertensives Kombinationspräparat.
DE3160552D1 (en)	1983-08-11	Medicine containing a biflavanone compound
DE3669713D1 (de)	1990-04-26	Alkylaminoamide und ihre salze, ihre herstellung, ihre verwendung als arzneimittel und diese verbindungen enthaltende zusammensetzungen.
GB1525844A (en)	1978-09-20	2-carbamoyl-1,2,4,5-tetrahydro-3h-2-benzazepin-3-ones
RU98119413A (ru)	2000-08-27	Способ лечения злокачественных новообразований